Skip to main content
. 2020 Feb 20;10:3061. doi: 10.1038/s41598-020-59898-0

Table 3.

Alterations in gene expression ain Fth1+/+ and Fth1−/− BMDM upon FAC or hemin treatments, at 12 h.

Genes of interest BMDM genotype FAC Hemin
Fth1 Fth1+/+ 1.65 ± 0.83 2.94 ± 1.26
Fth1−/− 0.11 ± 0.05* 0.10 ± 0.03*
Ftl Fth1+/+ 3.38 ± 2.60 3.57 ± 0.16
Fth1−/− 4.61 ± 2.39 5.10 ± 0.27
Slc40a1 Fth1+/+ 3.92 ± 2.30 18.19 ± 0.27
Fth1−/− 11.53 ± 0.25 18.65 ± 14.23
Tfrc Fth1+/+ 1.39 ± 0.73 0.31 ± 0.14
Fth1−/− 1.0. ± 0.60 0.30 ± 0.32
Hmox1 Fth1+/+ 6.09 ± 6.70 20.19 ± 7.54
Fth1−/− 10.24 ± 9.00 17.07 ± 9.34
Sod2 Fth1+/+ 4.05 ± 2.45 4.65 ± 1.47
Fth1−/− 4.40 ± 2.08 5.06 ± 2.75
Cat Fth1+/+ 7.36 ± 5.31 11.57 ± 1.87
Fth1−/− 14.22 ± 0.42 17.85 ± 3.69
Trxr Fth1+/+ 6.34 ± 5.58 16.33 ± 8.17
Fth1−/− 6.16 ± 3.24 11.50 ± 1.98
Gclc Fth1+/+ 1.68 ± 0.71 12.11 ± 7.23
Fth1−/− 2.48 ± 0.18 3.64 ± 1.66

aThe values are calculated as the fold change relative to the Fth1+/+ non-treated cells, and represent the mean ± SD of three independent cultures per condition; two-way ANOVA *p < 0.05.